Anixa Biosciences
ANIX
58 hedge funds and large institutions have $17.6M invested in Anixa Biosciences in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 4 closing their positions.
425% more call options, than puts
Call options by funds: $126K | Put options by funds: $24K
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
43% more capital invested
Capital invested by funds: $12.3M → $17.6M (+$5.27M)
9% more funds holding
Funds holding: 53 → 58 (+5)
0.06% more ownership
Funds ownership: 17.39% → 17.45% (+0.06%)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$137K |
| 2 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$73.2K |
| 3 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$64.9K |
| 4 |
TSWM
Tyler-Stone Wealth Management
Beachwood,
Ohio
|
+$64.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$58.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$201K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$49.3K |
| 3 |
Bank of New York Mellon
New York
|
-$44K |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$40.7K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$38.8K |
ANIX Hedge Fund Activity: Q3 2024 in Review
58 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2024, worth a combined $17.6M — up 43% from $12.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ANIX positions and 4 closed out — a net gain of 5 holders — while 10 added to existing stakes and 13 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $137K. The largest seller was D.A. Davidson & Co, cutting an estimated $201K.
- 58 institutional investors held Anixa Biosciences (ANIX) as of Q3 2024, up from 53 in Q2 2024.
- Funds reported $17.6M of Anixa Biosciences stock for Q3 2024, up 43% quarter-over-quarter.
- 9 funds opened new Anixa Biosciences positions in Q3 2024 and 4 closed out, a net change of +5 holders.
- The largest Anixa Biosciences buyer in Q3 2024 was Marshall Wace, an estimated $137K added.
- The largest Anixa Biosciences seller in Q3 2024 was D.A. Davidson & Co, an estimated $201K sold.
Based on aggregated 13F filings for Q3 2024.